Table 2. Characteristics of included studies reporting vaccination coverage for SBV.
| First author and year
of publication |
Setting | Vaccine | Selection
criteria |
Targeted population |
Vaccinated population |
Age
range |
Coverage |
|---|---|---|---|---|---|---|
| Raesima et al., 2015 | Urban | HPV | Grade/Age | 2488 | 1967 | 9–14+ | 79% |
| Binagwaho et al., 2012 | Urban/rural | HPV | Grade | 94141 | 88927 | 12 | 94.4% |
| Moodley et al., 2013 | Rural | HPV | Grade/Age | 963 | 938 | 9–14 | 97.4% |
| Snyman et al., 2015 | Rural | HPV | Grade/Age | 965 | 495 | 9–14 | 51.2% |
| Botha et al., 2015 | Urban/rural | HPV | Grade | 3465 | 1859 | 9–12 | 53.7% |
| Watson-Jones
et al.,
2012 |
Urban/rural | HPV | Grade/Age | 5532 | 4211 | 12–13 | 76.1% |
| La Montagne
et al.,
2011 |
Rural | HPV | Grade | 2008: 3459 | 3131
2009: 2835 | 2512 |
- | 90.5%
88.6% |
| Katagwa et al., 2014 | Rural | HPV | Age | 415 | 176 | 9–19 | 42.4% |